NDC 41167-0310

Zantac 150 Maximum Strength

Ranitidine Hydrochloride

Zantac 150 Maximum Strength is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Chattem, Inc.. The primary component is Ranitidine Hydrochloride.

Product ID41167-0310_09ec7ce6-df1a-432f-b64a-afb1a7554a59
NDC41167-0310
Product TypeHuman Otc Drug
Proprietary NameZantac 150 Maximum Strength
Generic NameRanitidine Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-04-03
Marketing CategoryNDA / NDA
Application NumberNDA021698
Labeler NameChattem, Inc.
Substance NameRANITIDINE HYDROCHLORIDE
Active Ingredient Strength150 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 41167-0310-0

1 POUCH in 1 CARTON (41167-0310-0) > 1 TABLET in 1 POUCH
Marketing Start Date2018-11-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 41167-0310-1 [41167031001]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-10-12

NDC 41167-0310-9 [41167031009]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-7 [41167031007]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-6 [41167031006]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-8 [41167031008]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-2 [41167031002]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-08-17

NDC 41167-0310-4 [41167031004]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-5 [41167031005]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-04-03

NDC 41167-0310-3 [41167031003]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-08-17

NDC 41167-0310-0 [41167031000]

Zantac 150 Maximum Strength TABLET
Marketing CategoryNDA
Application NumberNDA021698
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-11-11

Drug Details

Active Ingredients

IngredientStrength
RANITIDINE HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:78380bf5-7ab6-42da-a02c-24644db778ff
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 827189
  • 198191

    • NDC Crossover Matching brand name "Zantac 150 Maximum Strength" or generic name "Ranitidine Hydrochloride"

    NDCBrand NameGeneric Name
    21130-003Acid ReducerRanitidine Hydrochloride
    46084-031APTIDINERANITIDINE HYDROCHLORIDE
    0440-2300RanitidineRanitidine Hydrochloride
    11822-4727RanitidineRanitidine Hydrochloride
    11822-6051RanitidineRanitidine Hydrochloride
    11822-6052RanitidineRanitidine Hydrochloride
    11822-6107RanitidineRanitidine Hydrochloride
    37808-302RanitidineRanitidine Hydrochloride
    37808-303RanitidineRanitidine Hydrochloride
    41163-353RanitidineRanitidine Hydrochloride
    43353-952RanitidineRanitidine Hydrochloride
    49035-117RanitidineRanitidine Hydrochloride
    49035-353RanitidineRanitidine Hydrochloride
    50090-4353RanitidineRanitidine Hydrochloride
    0615-1354Ranitidine HydrochlorideRanitidine Hydrochloride
    0781-1883Ranitidine HydrochlorideRanitidine Hydrochloride
    0781-1884Ranitidine HydrochlorideRanitidine Hydrochloride
    0781-2855Ranitidine HydrochlorideRanitidine Hydrochloride
    0781-2865Ranitidine HydrochlorideRanitidine Hydrochloride
    15127-711Ranitidine HydrochlorideRanitidine Hydrochloride
    21695-337Ranitidine HydrochlorideRanitidine Hydrochloride
    21695-338Ranitidine HydrochlorideRanitidine Hydrochloride
    42291-735Ranitidine HydrochlorideRanitidine Hydrochloride
    42291-736Ranitidine HydrochlorideRanitidine Hydrochloride
    42291-766Ranitidine HydrochlorideRanitidine Hydrochloride
    42291-767Ranitidine HydrochlorideRanitidine Hydrochloride
    51079-879Ranitidine HydrochlorideRanitidine Hydrochloride
    51407-097Ranitidine HydrochlorideRanitidine Hydrochloride
    51407-098Ranitidine HydrochlorideRanitidine Hydrochloride
    0173-0393ZANTACranitidine hydrochloride
    41167-0310Zantac 150Ranitidine Hydrochloride
    41167-0320Zantac 150Ranitidine Hydrochloride
    41167-0300Zantac 75Ranitidine Hydrochloride

    Trademark Results [Zantac 150]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANTAC 150
    ZANTAC 150
    78427712 3080635 Live/Registered
    CHATTEM, INC.
    2004-06-01
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.